Yes, China has lifted zero Covid policy but yet to allow the people to renew their passports to travel. No passport, no traveling. Will the people of China bringing in the possibility of mutated Covid virus to foreign countries…? Hmm… As one of the Genting Berhad shareholders, I m happy to see Genting back on track again… Cheers! Happy New Year 2023!
Las Vegas Sands Corp share price moving north since the abolishment of zero Covid policy in China. We will see the similar trend in Genting Berhad. Hold tight and enjoy the ride!
Genting Berhad has cash per share of 5.97 with book value of 8.20, revenue breaking new high, turning profitability, and now Genting Berhad trading at 4.48, therefore this doesn’t make sense… scoop the bottom while you could before the smart money starting to push up above 5+ very soon…
Just got back from up high. Contributed to Uncle Lim unfortunately :p Crowd not bad for a weekday. 2 more trading days before we start a brand new year. HUAT AH!!!
KUALA LUMPUR: The tourism industry is all set to receive tourists from China in stages as that country eases its overseas travel restrictions from Jan 8.
Malaysian Inbound Tourist Association (Mita) president Uzaidi Udanis (pic) said China's decision to scrap quarantine measures for travellers is hoped to bring in about three million travellers next year.
Uzaidi said Chinese tourists are an important contributor to the country's economy as they are known to be big spenders.
YES DONT WORRY ABOUT USA RECESSION THE CHINESE AFTER BEING COOPED UP FOR SO LONG WILL TRAVEL AND GAMBLE ALLDAY ERRDAY IN CASINO DE GENTING AND STIMULATE THE WORLD ECONOMY IN TONGSAN WE TRUST !
Why value investors should not miss Genting, Gem of 2023?
First of all, in the midst of economic recession, cash is king! Genting Berhad has cash per share of 5.97 with book value of 8.20 per share. To boost the cash reserve, Genting Berhad is going to auction off Miami property, which it acquired in 2011 for $236 million. This Miami property worth more than $1000 million at current market value.
Next, China's move to ban gambling activities throughout the country with the exception of Macau. In addition, China government abolished the Zero Covid Policy. This means that the citizens no longer need to be quarantined, and likely to boost citizens' travel to other countries, including Singapore/ Malaysia, home to one of the leading casinos in the region.
After the tight restrictions of movement for two years, personally expecting China's high rollers would demonstrate retaliative spending and gambling at casinos in Asia. Singapore/ Malaysia will get the largest slice of the pie despite competition from neighbouring countries like Australia and Philippines because the locals in Singapore/ Malaysia could speak mandarin, apart from competitive advantage on currency exchange.
Even in this time of writing, all hotels under Genting are all fully booked at premium price (at least double price compared with pre-pandemic rates) and premium outlets are also packed with visitors. This clearly see the post-pandemic retaliatory spending nature of the citizens mainly from Malaysia and Singapore. Simple imagination and entry level math calculations would bring you to this conclusion that Genting business will become even more lucrative with the influx of tourists from China.
Not to forget, Genting Berhad holds 20.33% TauRx Pharmaceuticals Ltd. Interestingly, TauRx has submitted its Alzheimer’s drug for regulatory approvals in the US and Canada. Assuming TauRx worth US$15 billion (RM67.50billion), and in this time of writing, Genting Berhad traded at RM4.50 per share with market capitalisation of RM17.41 billion, then Genting Berhad shares should worth more than RM8 per share.
All in all, Genting will be the one of the best investment in 2023. Creme de la creme!
To all Genting shareholders, I wish you all, Happy New Year 2023 with zillion fruitful returns!
The prospect of cash-rich Chinese flocking to shopping streets across the world boosted luxury stocks this week, as China accounts for 21% of the world's 350 billion euro ($371.91 billion) luxury goods market.
As the Lunar New Year holiday - typically a peak travel period for Chinese tourists - starts on Jan 21, some businesses are already gearing up.
Sofitel Sentosa in Singapore is creating Lunar New Year packages aimed at Chinese visitors, including a hotpot buffet and romantic packages for couples, said Cavaliere Giovanni Viterale, general manager of that hotel and the upcoming Raffles Sentosa, as the company bets that a travel rebound will come "with a vengeance".
Capital A (Airasia), PN17 company, starts moving, up more than 4%… Genting Berhad, cash rich FA intact company, will rocket up! Happy New Year 2023! Year 2023 is Tourism theme!
Expecting 3 millions tourists arrival from China year 2023. Good sentiments in this holiday seasons for share price. Nevertheless, a much improved upcoming QR and positive development for the Alzheimer drugs are still needed to move the price higher.
Biogen set an "unjustifiably high" price by initially setting Aduhelm's price at $56,000 per year despite a lack of demonstrated clinical benefit in a broad patient population, the report said, adding that the company's own internal projections showed it expected the drug to be a burden to Medicare and costly to patients.
We wait for GenB TauRx with highest safety profile.
Just GE15 result out local institution net selling total 93mil of GenB share and all scooped by retailer. Unfortunately, PH form a unity gov and local institution loss big on the bet. Until today only Foreign institution mopped up small portion of 16mil net GenB share.
<< Approved for a broader population>> The FDA also approved the drug for “people with Alzheimer’s disease,” a far broader population than was studied in Biogen’s clinical trials.
The investigation found that Biogen planned an aggressive marketing campaign to launch the drug, intending to spend more than $3.3 billion on sales and marketing between 2020 and 2024 – more than 2½ times what it spent to develop Aduhelm. ------------------------------------
USD3.3B budget for sales and marketing??? Seems more likely sales commission kickbacks to doctors who dare to prescribe ineffective and dangerous Aduhelm to their patients.
I think Biogen/Eisai already spent close to US$100m on PR of Lecanemab hence all the positive headline news around the world. Unfortunately Taurx does not have that kind of money and budget to burn on PR, lobbying groups and key-opinion-leaders, etc. We only have the science and safety profile to back us. Phase 3 MCI 16mg patients at 18 mths can totally halt decline plus REVERSAL is what the world needs now to stop AD pandemic.
neohts, WOW, if really 20c come true, whoopee ! Very high div leh. Now, how to know this is really coming ? If real, everyone should share & buy buy buy
If Q4 net profit is very strong, we may see a small overall net profit for year 2022. As usual, LKT will declare high dividend by utilising previous decades' profit reserves. LKT is in personal financial distress n needs the high dividend more desperately than us :p
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
James_Bond
3,486 posts
Posted by James_Bond > 2022-12-28 06:45 | Report Abuse
Yes, China has lifted zero Covid policy but yet to allow the people to renew their passports to travel. No passport, no traveling. Will the people of China bringing in the possibility of mutated Covid virus to foreign countries…? Hmm… As one of the Genting Berhad shareholders, I m happy to see Genting back on track again… Cheers! Happy New Year 2023!